Sixteen diverse laboratory mouse reference genomes define strain-specific haplotypes and novel functional loci

We report full-length draft de novo genome assemblies for 16 widely used inbred mouse strains and find extensive strain-specific haplotype variation. We identify and characterize 2,567 regions on the current mouse reference genome exhibiting the greatest sequence diversity. These regions are enriched for genes involved in pathogen defence and immunity and exhibit enrichment of transposable elements and signatures of recent retrotransposition events. Combinations of alleles and genes unique to an individual strain are commonly observed at these loci, reflecting distinct strain phenotypes. We used these genomes to improve the mouse reference genome, resulting in the completion of 10 new gene structures. Also, 62 new coding loci were added to the reference genome annotation. These genomes identified a large, previously unannotated, gene (Efcab3-like) encoding 5,874 amino acids. Mutant Efcab3-like mice display anomalies in multiple brain regions, suggesting a possible role for this gene in the regulation of brain development.

Loss of Mrap2 is associated with Sim1 deficiency and increased circulating cholesterol

Melanocortin receptor accessory protein 2 (MRAP2) is a transmembrane accessory protein predominantly expressed in the brain. Both global and brain-specific deletion of Mrap2 in mice results in severe obesity. Loss-of-function MRAP2 mutations have also been associated with obesity in humans. Although MRAP2 has been shown to interact with MC4R, a G protein-coupled receptor with an established role in energy homeostasis, appetite regulation and lipid metabolism, the mechanisms through which loss of MRAP2 causes obesity remains uncertain. In this study, we used two independently derived lines of Mrap2 deficient mice (Mrap2(tm1a/tm1a)) to further study the role of Mrap2 in the regulation of energy balance and peripheral lipid metabolism. Mrap2(tm1a/tm1a) mice have a significant increase in body weight, with increased fat and lean mass, but without detectable changes in food intake or energy expenditure. Transcriptomic analysis showed significantly decreased expression of Sim1, Trh, Oxt and Crh within the hypothalamic paraventricular nucleus of Mrap2(tm1a/tm1a) mice. Circulating levels of both high-density lipoprotein and low-density lipoprotein were significantly increased in Mrap2 deficient mice. Taken together, these data corroborate the role of MRAP2 in metabolic regulation and indicate that, at least in part, this may be due to defective central melanocortin signalling.

A new role for lipocalin prostaglandin d synthase in the regulation of brown adipose tissue substrate utilization

In this study, we define a new role for lipocalin prostaglandin D synthase (L-PGDS) in the control of metabolic fuel utilization by brown adipose tissue (BAT). We demonstrate that L-PGDS expression in BAT is positively correlated with BAT activity, upregulated by peroxisome proliferator-activated receptor γ coactivator 1α or 1β and repressed by receptor-interacting protein 140. Under cold-acclimated conditions, mice lacking L-PGDS had elevated reliance on carbohydrate to provide fuel for thermogenesis and had increased expression of genes regulating glycolysis and de novo lipogenesis in BAT. These transcriptional differences were associated with increased lipid content in BAT and a BAT lipid composition enriched with de novo synthesized lipids. Consistent with the concept that lack of L-PGDS increases glucose utilization, mice lacking L-PGDS had improved glucose tolerance after high-fat feeding. The improved glucose tolerance appeared to be independent of changes in insulin sensitivity, as insulin levels during the glucose tolerance test and insulin, leptin, and adiponectin levels were unchanged. Moreover, L-PGDS knockout mice exhibited increased expression of genes involved in thermogenesis and increased norepinephrine-stimulated glucose uptake to BAT, suggesting that sympathetically mediated changes in glucose uptake may have improved glucose tolerance. Taken together, these results suggest that L-PGDS plays an important role in the regulation of glucose utilization in vivo.

Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation

Obesity and type 2 diabetes mellitus are the major noncommunicable public health problem of the 21st century. The best strategy to tackle this problem is to develop strategies to prevent/treat obesity. However, it is becoming clear that despite successful research identifying weight regulatory pathways, the development of the obesity epidemic is outpacing scientific progress. The lack of success controlling the obesity epidemic in an aging population will result in another subsequent uncontrolled epidemic of complications. Our research focuses on the mechanisms causing lipotoxicity aiming to identify suitable strategies to prevent or at least retard the development of the metabolic syndrome. Previous work using transgenic and knockout mouse models has shown an interplay between white adipose tissue and skeletal muscle linking fatty acid (FA) synthesis with reciprocal effects on FA oxidation. Work from our lab and others suggests that defective adipose tissue is a key link between obesity, insulin resistance and type 2 diabetes mellitus by promoting the development of lipotoxicity in peripheral tissues. We propose a series of models to describe the process by which the adipose tissue could react to an energy-rich environment and responds depending on genetic and physiological factors, impacting on the functions of other peripheral tissues. We suggest that by examining hypotheses that encompass multiple organs and the partitioning of energy between these organs, a suitable strategy can be devised for the treatment of chronic obesity.

Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein

In herpes simplex virus (HSV) the small secreted glycoprotein gL forms a heterodimer with the transmembrane envelope glycoprotein gH. Here we identify the human herpesvirus 6 (HHV-6) gL gene, express HHV-6 gL and gH homologues, and examine interactions between HHV-6 gH and gL. The HHV-6 gL gene encoded a glycoprotein with an amino acid sequence which showed closest similarity to the human cytomegalovirus (HCMV) gL homologue (18% identity). Products of HHV-6 gH and gL genes were characterized in an in vitro transcription-translation system and in a transient in vivo expression system. Both gH and gL were transcribed and translated in vitro to give products of apparent M(r) of 65K and 28K in SDS-PAGE, and these could be processed by addition of microsomes to 110K and 40K, respectively. To study gH/gL interactions, gH was tagged with the nine amino acid epitope for monoclonal antibody LP14 (anti-HSV-1 gD). LP14 and a human serum sample specifically immunoprecipitated gH and a stable complex of gH and gL co-expressed in an in vivo vaccinia virus-T7 system. The gH and gL produced in this in vivo expression system corresponded to the M(r)s of the fully processed glycoproteins identified in the in vitro system. The gH expressed together with gL was recognized by human sera more easily than when examined on its own in immunofluorescence assays. Dual expression of gH and gL in transfected T lymphocytes (JJhan) caused reactions with 75% of human sera tested (12 HHV-6-positive, HCMV-negative serum samples), but gL expressed alone was not recognized by these sera. The immunofluorescence studies also showed that the glycoproteins were localized in Golgi-like bodies in fibroblasts, but occurred throughout the endoplasmic reticulum in T lymphocytes, the normal cellular target for HHV-6. These results show the identification of the HHV-6 homologue to the HCMV and HSV gL genes, identification and production of HHV-6 gH and gL expressed both in vitro and in vivo, complex formation between these glycoproteins, and evidence that this complex may be localized differently in fibroblasts as compared to T lymphocytes and that it is immunogenic.